Hi Ron,
Total sales was 14.4 million and I believe 78% of that was from Waterlase sales. Assuming ASP of ฻k will get you around 261 units. My notes say that they mentioned 250 units during the conference call so that ฻K estimate of yours is pretty close. ASP is a 80/20 blend of north American and international sales and I believe the international realizations per unit can be quite different than NA ASP depending on exchange rates etc.
So they made 轀K/250 or about 񘣌 per machine and uncle sam and the Governator gets 񘔖 per machine. Other expenses are cost of goods (includes materials, assembly, packaging etc), R&D (has been running 10% of year-ago sales) , overhead and sales expenses take up the rest of pie. Sales expenses (marketing, training etc…) typically eats up a bigger proportion of the pie during the first quarter. Impressive sales. Management could have done a better job explaining the increase in overhead burden (general and adminstrative). Otherwise no complaints.
Forgot to add my disclosure:
I own Biolase stock
(Edited by lagunabb at 8:54 am on May 3, 2004)